Creation of a Multicenter National Registry for Peripartum Cardiomyopathy. — PPCMREGISTRY  

Peripartum Cardiomyopathy Clinical Trial

Official title: Creation of a Multicenter National Registry for Peripartum Cardiomyopathy: a Wide, Multidisciplinary and Translational Perspective to Achieve Personalized Medicine for a Rare Disease in Women

Status Recruiting

Clinical Trial Summary

Peripartum cardiomyopathy (PPCM) is a rare, severe and potentially life-threatening disorder of largely unknown etiology and pathophysiology, with unexplained geographical differences and heterogeneous presentation. Investigators hypothesize that a network-based multidisciplinary strategy integrating clinical and molecular phenotyping of PPCM patients might anticipate diagnosis, optimize treatments, and identify novel mechanisms to achieve the unmet goal of personalized medicine.

Clinical Trial Description

Specific aims of this study are: a) to create a multicenter pilot registry of PPCM in different areas in Italy to assess incidence and prevalence of this rare disease, associated comorbidities and risk factors. b) to deeply characterize identified PPCM patients through clinical, imaging, genetic, biochemical, and molecular phenotyping. c) to gain novel mechanistic information on PPCM by performing deep clinical and molecular phenotyping in available biobanks samples of patients with PPCM and healthy controls. ;

Related Conditions & MeSH terms

• Cardiomyopathies
• Peripartum Cardiomyopathy

• NCT number: NCT05878041
• Study type: Observational [Patient Registry]
• Source: Federico II University
• Contact: Cinzia Perrino
• Phone: +39 081 7462223
• Email: perrino@unina.it
• Status: Recruiting
• Start date: February 21, 2024
• Completion date: May 19, 2026